scholarly article | Q13442814 |
P356 | DOI | 10.1210/JC.2015-2335 |
P698 | PubMed publication ID | 26445112 |
P50 | author | Jens Juul Holst | Q28373106 |
Bolette Hartmann | Q51055821 | ||
Jonatan Ising Bagger | Q58110286 | ||
Filip K Knop | Q59659637 | ||
Tina Vilsbøll | Q60393741 | ||
P2093 | author name string | Birgitte Andersen | |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | appetite | Q28578 |
glucagon | Q28163629 | ||
P304 | page(s) | 4541-4552 | |
P577 | publication date | 2015-10-07 | |
P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
P1476 | title | Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure. | |
P478 | volume | 100 |
Q52656812 | A Randomized Trial Investigating the Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Semaglutide Once-Weekly in Healthy Male Japanese and Caucasian Subjects. |
Q87841816 | All in one: Researchers create combination drugs for diabetes and obesity |
Q46531147 | Characterization and quantification of oxyntomodulin in human and rat plasma using high-resolution accurate mass LC-MS. |
Q57791608 | Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification scheme |
Q47252691 | Does endogenous GLP-1 affect resting energy expenditure and fuel selection in overweight and obese adults? |
Q92709175 | Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial |
Q104064811 | Functions of galanin, spexin and kisspeptin in metabolism, mood and behaviour |
Q93000811 | Gastrointestinal hormones and regulation of gastric emptying |
Q38730622 | Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke |
Q37009157 | Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma |
Q47161786 | Recent advances in understanding/managing type 2 diabetes mellitus |
Q30368984 | Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates |
Q89230553 | Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates |
Q55234575 | Sustained effect of glucagon on body weight and blood glucose: Assessed by continuous glucose monitoring in diabetic rats. |
Q60920688 | The Regulation of Peripheral Metabolism by Gut-Derived Hormones |
Q38853094 | The effect of a subcutaneous infusion of GLP-1, OXM and PYY on Energy intake and Expenditure in Obese volunteers |
Search more.